Research

And Grants

Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.

Submit Grant Application

Home > Research and Grants

The Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.

Grant Approval Process

Grant Approval Process

The Cure Starts Now has funded $29,679,360 USD in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 196 grants at over 100 hospitals in 29 countries.






The International DIPG/DMG Registry - $23,683

Amount
$23,683.00 USD
Date
February 2026

Sub-award for DIPG/DMG Registry in Canada

Columbia University Irving Medical Center – $100,000

Amount
$100,000.00 USD
Date
December 2025

Targeting DIPG Through Therapeutic Dietary Intervention

Grant Information

Monash University – $100,000 USD / $149,912.70 AUD

Amount
$100,000.00 USD
Date
December 2025

Exploiting Nucleolar Vulnerabilities in Paediatric High-Grade Gliomas

Grant Information

Johns Hopkins University School of Medicine – $50,000

Amount
$50,000.00 USD
Date
December 2025

Identifying Novel Treatment Combinations Targeting ERK Signaling Dependence in Pediatric Glioma

Grant Information

University of Virginia Medical Center – $100,000

Amount
$100,000.00 USD
Date
December 2025

Targeting Alternatively Activated Macrophages in Diffuse Midline Glioma

Grant Information

The University of Sydney – $100,000 USD / $149,912.70 AUD

Amount
$100,000.00 USD
Date
December 2025

Targeting mitochondrial metabolism as a novel therapeutic strategy for treatment of Diffuse Midline Gliomas

Grant Information

Kiragen Bio – $50,000

Amount
$50,000.00 USD
Date
December 2025

Engineering Suppression-Resistant CAR-T Cells for the Treatment of Pediatric DIPG by Overcoming the Tumor Microenvironment

Grant Information

Seattle Children’s Hospital – $50,000

Amount
$50,000.00 USD
Date
December 2025

Thyroid Hormone Therapy in Combination with Chemotherapy for Pediatric Medulloblastoma

Grant Information

University of Rome Tor Vergata – $100,000 USD / €85,232 EUR

Amount
$100,000.00 USD
Date
December 2025

Reprogramming the tumor immune landscape: combined use of NK cells and radiotherapy in high-risk medulloblastoma

Grant Information

Weill Cornell Medicine – $50,000

Amount
$50,000.00 USD
Date
December 2025

A Phase 1a Open-label Study Evaluating the Safety of 177Lu-DTPA-omburtamab delivered by CED in non-progressive DMG patients previously treated with external beam radiation therapy

Grant Information

The Hebrew University of Jerusalem – $50,000 USD / 159,344.25 New Israeli Shekels

Amount
$50,000.00 USD
Date
December 2025

Uncovering and Exploiting Tumor Vulnerabilities in Medulloblastoma via Integrated Genomic and Preclinical Platforms.

Grant Information

Cincinnati Children’s Hospital Medical Center – $75,000

Amount
$75,000.00 USD
Date
December 2025

Multiomic Characterization of Central Nervous System Tumors Using Whole Methylome and Comprehensive High-Depth DNAseq and RNAseq to Assess Impact on Historical Patient Diagnoses and Outcomes

Grant Information

University of Alabama at Birmingham Hospital - $200,000

Amount
$200,000.00 USD
Date
December 2025

Precision Immunotherapy for Diffuse Midline Glioma Targeting

Grant Information

Icahn School of Medicine at Mount Sinai – $100,000

Amount
$100,000.00 USD
Date
December 2025

Targeting DMG Microenvironment with LSD1 Inhibitors

Grant Information

Erasmus University Medical Center – $200,000 USD (€169,884.56)

Amount
$200,000.00 USD
Date
December 2025

Target-first: Development and Optimization of Targeted Radiopharmaceutical Therapies for Pediatric Brain Tumors; A World-First Translational Study

Grant Information